Cleared Traditional

K071913 - IMMUNOCAP ALLERGEN F338

K071913 is the FDA 510(k) clearance for IMMUNOCAP ALLERGEN F338 by Phadia AB. It is a Class 2 Immunology device (product code DHB) cleared through the Traditional 510(k) pathway after a 44-day FDA review.

K071913 · Phadia AB · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2007
Decision
44d
Days
Class 2
Risk

K071913 is an FDA 510(k) clearance for the IMMUNOCAP ALLERGEN F338, SCALLOP WITH MODEL(S): 14-4895-01. Classified as System, Test, Radioallergosorbent (rast) Immunological (product code DHB), Class II - Special Controls.

Submitted by Phadia AB (Uppsala, SE). The FDA issued a Cleared decision on August 24, 2007 after a review of 44 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5750 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Phadia AB devices

Submission Details

510(k) Number K071913 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 11, 2007
Decision Date August 24, 2007
Days to Decision 44 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
60d faster than avg
Panel avg: 104d · This submission: 44d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DHB System, Test, Radioallergosorbent (rast) Immunological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DHB System, Test, Radioallergosorbent (rast) Immunological

All 188
Devices cleared under the same product code (DHB) and FDA review panel - the closest regulatory comparables to K071913.
IMMULITE 2000 3GALLERGY SPECIFIC IGE ASSAY KIT
K083314 · Siemens Healthcare Diagnostics · Mar 2009
HY-TEC SPECIFIC AND TOTAL IGE EIA SYSTEM
K081217 · Hycor Biomedical, Inc. · May 2008
HY*TEC EXTENDED SPECIFIC IGE EIA, MCS ASSAY USING TECAN FREEDOM EVO RSP 200
K080322 · Hycor Biomedical, Inc. · Mar 2008
IMMULITE 2000 ALLERGEN-SPECIFIC IGE
K023152 · Diagnostic Products Corp. · Dec 2002
IMMULITE 2000 SPECIFIC ALLERGENS
K021206 · Diagnostic Products Corp. · May 2002
IMMULITE 2000 MIXED ALLERGEN PANELS
K021208 · Diagnostic Products Corp. · May 2002